What question did this study set out to answer?

The study aims to evaluate the neuroprotective effects of nodakenin against cerebral ischemia-reperfusion injury.

March 13, 20260 citations

Nodakenin attenuates cerebral ischemia-reperfusion injury by modulating the PI3K/AKT/NF-κB signaling pathway.

Key Points

The study aims to evaluate the neuroprotective effects of nodakenin against cerebral ischemia-reperfusion injury.
Conducted experiments to assess the impact of nodakenin on cerebral ischemia-reperfusion injury.
Analyzed its effects on the PI3K/AKT/NF-κB signaling pathway.
Evaluated neuroinflammation, oxidative stress, and ferroptosis levels in the model.
Nodakenin significantly reduced markers of neuroinflammation and oxidative stress.
It effectively decreased ferroptosis in the ischemic tissue.
The modulation of the PI3K/AKT/NF-κB pathway was confirmed as a key mechanism behind these protective effects.

Abstract

Nodakenin exerted neuroprotective effects against cerebral I/R injury by regulating the PI3K/AKT/NF-κB pathway to reduce neuroinflammation, oxidative stress and ferroptosis. These findings identify Nodakenin as a promising candidate for limiting secondary injury after ischemic stroke.

AI से पूछें

Bookmark

View Full Paper